Companies similar to ANAPTYSBIO INC (ANAB)
Health Care · NASDAQ
ANAPTYSBIO INC (ANAB)'s closest peers include Merck & Co. (MRK), Bristol Myers Squibb (BMY), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD) and AbbVie (ABBV). This peer set is drawn from ANAB's enriched company profile and is informational only — not financial advice.
Similar companies
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$136.30 (as of 2026-07-16) · market cap $167.2B
-
AbbVieABBVHealth Care
Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.
$254.39 (as of 2026-07-16) · market cap $431.3B
Not quite? Describe exactly what you want →
Peers are drawn from ANAB's enriched profile (the same similarity signal the chat uses for "companies like ANAB"). See the full profile: ANAPTYSBIO INC (ANAB).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.